BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 21871197)

  • 21. Financial impact of the GFC: health care spending across the OECD.
    Morgan D; Astolfi R
    Health Econ Policy Law; 2015 Jan; 10(1):7-19. PubMed ID: 25662194
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trends in cost sharing among selected high income countries--2000-2010.
    Hossein Z; Gerard A
    Health Policy; 2013 Sep; 112(1-2):35-44. PubMed ID: 23809913
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Health Care Spending in the United States and Other High-Income Countries.
    Papanicolas I; Woskie LR; Jha AK
    JAMA; 2018 Mar; 319(10):1024-1039. PubMed ID: 29536101
    [TBL] [Abstract][Full Text] [Related]  

  • 24. How much 'skin in the game' do medicare beneficiaries have? The increasing financial burden of health care spending, 1997-2003.
    Neuman P; Cubanski J; Desmond KA; Rice TH
    Health Aff (Millwood); 2007; 26(6):1692-701. PubMed ID: 17978388
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Health expenditure trends in OECD countries, 1990-2001.
    Huber M; Orosz E
    Health Care Financ Rev; 2003; 25(1):1-22. PubMed ID: 14997690
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Moral hazard and prescription medicine use in Australia--the patient perspective.
    Doran E; Robertson J; Henry D
    Soc Sci Med; 2005 Apr; 60(7):1437-43. PubMed ID: 15652677
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stochastic convergence of renewable energy consumption in OECD countries: a fractional integration approach.
    Solarin SA; Gil-Alana LA; Al-Mulali U
    Environ Sci Pollut Res Int; 2018 Jun; 25(18):17289-17299. PubMed ID: 29651729
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Being uninsured in 1996 compared to 1987: how has the experience of the uninsured changed over time?
    Taylor AK; Cohen JW; Machlin SR
    Health Serv Res; 2001 Dec; 36(6 Pt 2):16-31. PubMed ID: 16148958
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The pervasiveness of pharmaceutical expenditure inertia in the OECD countries.
    Okunade AA; Suraratdecha C
    Soc Sci Med; 2006 Jul; 63(1):225-38. PubMed ID: 16459005
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Health care expenditures: international comparisons, 1970-80.
    Simanis JG
    Soc Secur Bull; 1987 Oct; 50(10):19-24. PubMed ID: 3120328
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Out-of-pocket health spending by poor and near-poor elderly Medicare beneficiaries.
    Gross DJ; Alecxih L; Gibson MJ; Corea J; Caplan C; Brangan N
    Health Serv Res; 1999 Apr; 34(1 Pt 2):241-54. PubMed ID: 10199672
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmaceutical pricing and reimbursement reforms in Greece.
    Yfantopoulos J
    Eur J Health Econ; 2008 Feb; 9(1):87-97. PubMed ID: 17619920
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [International comparisons of institutional medical care expenditures--an analysis using the OECD health data bank].
    Shimmura K; Araki S
    Nihon Koshu Eisei Zasshi; 1990 Apr; 37(4):247-54. PubMed ID: 2131986
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost-related non-adherence to prescribed medicines among older adults: a cross-sectional analysis of a survey in 11 developed countries.
    Morgan SG; Lee A
    BMJ Open; 2017 Jan; 7(1):e014287. PubMed ID: 28143838
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prescription drug spending: contribution to health care spending and cost containment strategies.
    Rivers PA; Hall NG; Frimpong J
    J Health Care Finance; 2006; 32(3):8-19. PubMed ID: 18975728
    [TBL] [Abstract][Full Text] [Related]  

  • 36. How health insurance design affects access to care and costs, by income, in eleven countries.
    Schoen C; Osborn R; Squires D; Doty MM; Pierson R; Applebaum S
    Health Aff (Millwood); 2010 Dec; 29(12):2323-34. PubMed ID: 21088012
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of a generic substitution reform on patients' and society's expenditure for pharmaceuticals.
    Andersson K; Bergström G; Petzold MG; Carlsten A
    Health Policy; 2007 May; 81(2-3):376-84. PubMed ID: 16945449
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Health care spending growth: how different is the United States from the rest of the OECD?
    White C
    Health Aff (Millwood); 2007; 26(1):154-61. PubMed ID: 17211024
    [TBL] [Abstract][Full Text] [Related]  

  • 39. National health expenditures: a global analysis.
    Murray CJ; Govindaraj R; Musgrove P
    Bull World Health Organ; 1994; 72(4):623-37. PubMed ID: 7923542
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Revisiting out-of-pocket requirements: trends in spending, financial access barriers, and policy in ten high-income countries.
    Rice T; Quentin W; Anell A; Barnes AJ; Rosenau P; Unruh LY; van Ginneken E
    BMC Health Serv Res; 2018 May; 18(1):371. PubMed ID: 29776404
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.